Terms: = Liver cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
32 results:
1. No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor liver Transplantation.
Yang G; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yoon YI; Kang WH; Joo SH; Lee SG
Ann Transplant; 2024 Mar; 29():e942767. PubMed ID: 38439530
[TBL] [Abstract] [Full Text] [Related]
2. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
[TBL] [Abstract] [Full Text] [Related]
3. TuBG1 promotes hepatocellular carcinoma via atr/P53-apoptosis and cycling pathways.
Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
[TBL] [Abstract] [Full Text] [Related]
4. [Causes and prognosis analysis of hyperdynamic left ventricular ejection fraction in intensive care unit patients with sepsis].
Xiong F; Yang H; Yan J; Wang C; Jin Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):834-838. PubMed ID: 37593862
[TBL] [Abstract] [Full Text] [Related]
5. RHNO1 disruption inhibits cell proliferation and induces mitochondrial apoptosis via PI3K/Akt pathway in hepatocellular carcinoma.
Du D; Wang S; Li T; Liu Z; Yang M; Sun L; Yuan S
Biochem Biophys Res Commun; 2023 Sep; 673():96-105. PubMed ID: 37364391
[TBL] [Abstract] [Full Text] [Related]
6. Identification of CFHR4 as a Potential prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
Front Immunol; 2022; 13():892750. PubMed ID: 35812416
[TBL] [Abstract] [Full Text] [Related]
7. [Comparison of serum GP73 and p62 measurement to predict short-term prognosis in patients with HBV-related acute-on-chronic liver failure].
Gao W; Gao H; Yin CM; Yang SL; Fan XH; Liu CL; Li XQ; Jia NN
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):855-860. PubMed ID: 34638204
[No Abstract] [Full Text] [Related]
8. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
[TBL] [Abstract] [Full Text] [Related]
9. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract] [Full Text] [Related]
10. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract] [Full Text] [Related]
12. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract] [Full Text] [Related]
13. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion.
Li L; Li B; Zhang M
Medicine (Baltimore); 2019 Jul; 98(27):e16308. PubMed ID: 31277172
[TBL] [Abstract] [Full Text] [Related]
14. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
[TBL] [Abstract] [Full Text] [Related]
15. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract] [Full Text] [Related]
16. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
17. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract] [Full Text] [Related]
18. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.
Yang P; Si A; Yang J; Cheng Z; Wang K; Li J; Xia Y; Zhang B; Pawlik TM; Lau WY; Shen F
Surgery; 2019 Apr; 165(4):721-730. PubMed ID: 30554724
[TBL] [Abstract] [Full Text] [Related]
19. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
Bayard Q; Meunier L; Peneau C; Renault V; Shinde J; Nault JC; Mami I; Couchy G; Amaddeo G; Tubacher E; Bacq D; Meyer V; La Bella T; Debaillon-Vesque A; Bioulac-Sage P; Seror O; Blanc JF; Calderaro J; Deleuze JF; Imbeaud S; Zucman-Rossi J; Letouzé E
Nat Commun; 2018 Dec; 9(1):5235. PubMed ID: 30531861
[TBL] [Abstract] [Full Text] [Related]
20. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract] [Full Text] [Related]
[Next]